There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

A research team co-led by UCLA investigators has found that pembrolizumab, an immunotherapy drug that helps the immune system ...

Programmed death-1 (PD-1) inhibition with pembrolizumab led to durable remission in 31.3% of patients with early acute ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Eli Lilly and Company, in collaboration ...

The field of genitourinary (GU) oncology has seen significant developments over recent decades, yet challenges in treatment outcomes remain. Current ...